secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001367644-24-000155
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions gets FDA approval for ACAM2000 mpox indication
--------------------------------------------------------------------

- FDA approved sBLA for ACAM2000 to prevent mpox in high-risk individuals based on animal study safety/efficacy data.
- ACAM2000 is a single-dose, percutaneously administered smallpox vaccine first approved in 2007.
- Emergent will donate 50,000 doses for potential deployment across impacted Central African countries.
- Company filed Expression of Interest with WHO for Emergency Use Listing amid mpox outbreak.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000155/0001367644-24-000155-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000155/ebs-20240829.htm
  HTML page:      https://secwatch.observer/filing/0001367644-24-000155

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer